Crispr Therapeutics shares tumble after significant earnings miss
Director Dennis V. Arriola of Meritage Homes CORP (NYSE:MTH), currently trading at $69.47 and showing signs of undervaluation according to InvestingPro analysis, recently purchased shares of the company’s stock, according to a Form 4 filing with the Securities and Exchange Commission.
The filing reveals that Arriola engaged in multiple purchase transactions. On December 31, 2024, Arriola acquired 20 shares at $77.21, totaling $1,544.40. On July 25, 2025, Arriola bought 2,200 shares at $70, amounting to $154,000. The total value of shares purchased was $155,544, with prices ranging from $70.0 to $77.21. The company, with a market capitalization of $4.96 billion, currently trades at an attractive P/E ratio of 7.85. Want deeper insights into insider trading patterns and valuation metrics? Check out the comprehensive research available on InvestingPro.
Additionally, the report indicates the acquisition of shares through a dividend reinvestment program. 45 shares were acquired on March 31, 2025, at $69.62, and 47 shares were acquired on June 30, 2025, at $66.62. The total value of shares acquired through the dividend reinvestment program was $6,264, with prices ranging from $66.62 to $69.62. The company currently offers a dividend yield of 2.48%, with a 14.67% dividend growth over the last twelve months.
Following these transactions, Arriola directly holds 3,200 MTH Common Shares and indirectly holds 9,512 shares in trust. The stock currently trades near its 52-week low of $59.27, while maintaining strong liquidity with current assets exceeding short-term obligations.
In other recent news, Meritage Corporation reported its financial results for the second quarter of 2025, exceeding Wall Street expectations. The company achieved an earnings per share (EPS) of $2.04, surpassing the forecast of $1.98. Additionally, Meritage’s revenue reached $1.61 billion, beating the anticipated $1.59 billion. Despite these positive financial results, the company’s stock experienced a decline, reflecting investor concerns about broader market trends and internal challenges. These developments highlight the complexities companies face even when financial performance is strong. Analyst firms have not yet updated their ratings following the earnings announcement, leaving investors to interpret the results within the current market context. As the company navigates these challenges, stakeholders will be closely monitoring any further updates or strategic moves.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.